Essex Woodlands Management, Inc.
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), Essex Woodlands Management, Inc. reported 7 stock positions worth $433.2 million. Its top holding was Mimedx (MDXG) at 62.6% of the portfolio, followed by Bioventus Class A (BVS, 31.6%) and Tela Bio (TELA, 2.9%). Compared with Q3 2024, it reduced 1. The biggest sale was Eyepoint (EYPT, shares −25%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001542339
- Portfolio Value
- $433.2M (Q4 2024)
- SEC Filing
- 0000908834-25-000074 ↗ filed Feb 13, 2025
Holdings Value
Holdings 7 stocks · $433.2M
| MDXG Mimedx Group Inc. | 62.61% | 28,195,249 | $271.2M | No change |
| BVS Bioventus Inc. Class A | 31.56% | 13,021,324 | $136.7M | No change |
| TELA Tela Bio Inc. | 2.87% | 4,110,709 | $12.4M | No change |
| EYPT Eyepoint Inc. | 2.01% | 1,169,857 | $8.7M | Reduce -24.6% |
| MNOV Medicinova Inc. | 0.54% | 1,105,941 | $2.3M | No change |
| RVNC Revance Therapeutics Inc. | 0.32% | 457,085 | $1.4M | No change |
| VENUS CONCEPT INC | 0.10% | 1,089,190 | $414K | No change |
Portfolio Sells Q3 2024 → Q4 2024
| EYPT Eyepoint Inc. | Reduce -24.6% | 2.01% | −1.53 |
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $254.2M | BVS, MDXG, EYPT, TELA, MNOV |
| Q1 2026 | 5 | $250.5M | BVS, MDXG, EYPT, TELA, MNOV |
| Q4 2025 | 6 | $318.3M | MDXG, BVS, EYPT, TELA, MNOV |
| Q3 2025 | 6 | $307.1M | MDXG, BVS, EYPT, TELA, MNOV |
| Q2 2025 | 6 | $279.1M | MDXG, BVS, EYPT, TELA, MNOV |
| Q1 2025 | 6 | $346.7M | MDXG, BVS, EYPT, TELA, MNOV |
| Q4 2024 | 7 | $433.2M | MDXG, BVS, TELA, EYPT, MNOV |
| Q3 2024 | 7 | $350.4M | MDXG, BVS, EYPT, TELA, RVNC |
| Q2 2024 | 7 | $306.7M | MDXG, BVS, TELA, EYPT, MNOV |
| Q1 2024 | 7 | $344.8M | MDXG, BVS, EYPT, TELA, RVNC |